Pulmonary Arterial Hypertension Clinical Trials Database - Free Access to 389 Studies
Access comprehensive clinical trial information for Pulmonary Arterial Hypertension through Pure Global AI's free database. This collection includes 389 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 62 trials are actively recruiting participants.
Research for Pulmonary Arterial Hypertension is being conducted in United States of America, China, France and 7+ other countries. Leading sponsors include Actelion and United Therapeutics. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Open Label Study of Sildenafil in Subjects With Pulmonary Arterial Hypertension
An Open Label Access Study For Subjects Who Completed A1481156
Sotatercept on Central Cardiopulmonary Performance and Peripheral Oxygen Transport During Exercise in Pulmonary Arterial Hypertension
Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH
Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arterial Hypertension
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
Safety and Efficacy of BIA 5-1058 in PAH
A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS).
Supervised Endurance Training Among Pulmonary Arterial Hypertension Patients
Assessing the Utility of Submaximal CPET in Treatment Management of PAH
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension
Safety, Tolerability and Pharmacokinetics of L608 in Healthy Adults
A Study of Sotatercept in Japanese Pulmonary Arterial Hypertension (PAH) Participants (MK-7962-020)
Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
Untitled Trial
Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants
A Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
Pure Global AI provides free access to 389 clinical trials studying Pulmonary Arterial Hypertension, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Actelion, United Therapeutics, Novartis Pharmaceuticals, among others.